[1] |
LI Xiao-dan, CHEN Ming, ZHENG Ying, WANG Zhi-jian, HUANG Ren-chun.
Effects of Sertraline Combined with CCBT on Clinical Symptoms
and Self-Care Abilities in Patients with Post-Schizophrenia
Depression
[J]. ACTA NEUROPHARMACOLOGICA, 2025, 15(1): 19-.
|
[2] |
ZHANG Wei-jian, ZHAO Yun-hao, JIA Chong-ning, QIN Xue-mei, TIAN Jun-sheng.
Research Progress on the Treatment of Depression with Chinese
Medicine by Regulating Brain Sex Hormone Microenvironment
Homeostasis
[J]. ACTA NEUROPHARMACOLOGICA, 2025, 15(1): 25-.
|
[3] |
LI Hui, YANG Jin-shui, XUE Qian.
A Case of Huntington's Disease with Involuntary Movements
of the Limbs as the First Symptom Combined with Dysarthria
in the Early Stages of the Disease
[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(6): 31-.
|
[4] |
ZHANG Yuan-qing, LIN Yu, HUANG Li.
Study on the Effects of Vitamin D on DNA Methylation in
Alzheimer's Disease Cell Models
[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(6): 39-.
|
[5] |
ZHAO Yu-ting, YIN Hong-yan, GUO Chun-yan.
Explore the Mechanism of Paeoniae Radix Alba Delaying
Alzheimer's Disease Based on Network Pharmacology and
Molecular Docking
[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 1-.
|
[6] |
ZHOU Xin-mei, ZHU Li-ping.
Network Pharmacology Study of Sini SAN in the Treatment
of Post-Stroke Depression
[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 19-.
|
[7] |
ZHANG Xin, YAO Si-fan, MA Meng-fan, SHEN Li-xia.
Recent Progress in the Metabolomics of Alzheimer's Disease
[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(5): 47-.
|
[8] |
YAO Si-fan, ZHANG Xin, SHEN Li-xia.
Effects of Tau Protein on Mitochondrial Function in Alzheimer's
Disease
[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(4): 54-.
|
[9] |
WANG Tian-xu, LIU Ci, CUI Yong-yuan, ZHANG Xin, WU Miao-miao, SHEN Li-xia.
Explore the Mechanism of Quercetin in the Treatment
of Alzheimer's Disease by Network Pharmacology and
Molecular Docking
[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(2): 31-.
|
[10] |
ZHANG Ran-ran, WU Zhi-gang.
Research Progress of Neuroactive Steroid in the Treatment
of Depression
[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(1): 49-.
|
[11] |
YIN Hong-yan, YOU Si-han, GUO Chun-yan.
Research Progress of Core Markers and Other Markers of
Alzheimer's Disease
[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 45-.
|
[12] |
ZHU Jing-yi , FAN Jian-chun, YU Ai-mei.
Research Status on the Neuroprotective Effect of Probucol
[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(6): 50-.
|
[13] |
.
Exploring the Effect and Mechanism of Pterostilbene on Alzheimer’s Disease Based on Network Pharmacology
[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(5): 1-.
|
[14] |
HUANG He, LAN Yue-ying.
Clinical Efficacy of Amsulpride Combined with Duloxetine in Treatment of Depression in Forced Detoxification Patients
[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(5): 43-.
|
[15] |
HUANG Yu-li, LI Xiang-bo, YUAN li, TENG Jin-liang.
Research Progress on Clinical Efficacy and Adverse Reactions of Esketamine
[J]. ACTA NEUROPHARMACOLOGICA, 2023, 13(4): 13-.
|